Investment
Features
FeesSafety
Academy
More
Pluang+

Travel firms boost AI and efficiency investments despite economic uncertainty, focusing on near-term gains.

Market News
15 Sep 2026
PRNewsWire
View Source
Bullish
Travel firms boost AI and efficiency investments despite economic uncertainty, focusing on near-term gains.

Travel companies are maintaining or accelerating their AI and modernization investments amid ongoing global economic and geopolitical uncertainties, according to Sabre's new report. Most executives prioritize near-term efficiency, automation, and workforce tools to protect margins while keeping long-term modernization plans intact. The industry is shifting focus from volume growth to enhancing the value and profitability of existing bookings, with many investing in cost reduction and data analytics. This pragmatic approach positions travel firms to navigate current challenges and emerge stronger in the recovery phase.

Travel companies' AI and modernization investments provide context for Pluang's Technology sector market snapshot. As of Sep 15, 2026 18:13 WIB, out of 150 priced Technology-sector US stocks tradable on Pluang, 57 rose and 86 fell. Notable price changes include NOK (Nokia Corp) at USD 10.00 with a 1-day change of +3.57%, MSTR (Strategy Inc.) at USD 132.12 down -3.52%, and ASML (ASML Holding NV) at USD 1,625.24 up +3.18%.

More News

Ascendis Pharma gains full rights to TransCon tech, launches $400M buyback, and posts positive trial data.

Ascendis Pharma gains full rights to TransCon tech, launches $400M buyback, and posts positive trial data.

Ascendis Pharma A/S regained full control of its TransCon technology for metabolic diseases from Novo Nordisk, allowing it to independently develop and sell treatments, including for obesity. The company also authorized a $400 million share repurchas...

Market News
Bullish
3 hours ago
Deutsche Bank upgrades AstraZeneca to Hold after mixed drug trial results.

Deutsche Bank upgrades AstraZeneca to Hold after mixed drug trial results.

Deutsche Bank upgraded AstraZeneca's stock rating from Sell to Hold following mixed results from its drug trials. The lung disease drug tozorakimab showed strong Phase III results and received FDA priority review, signaling potential future growth. H...

Analyst Insights
Neutral
3 hours ago
Tesla rebounds with 52% US EV market share despite past sales collapse and political fallout.

Tesla rebounds with 52% US EV market share despite past sales collapse and political fallout.

Tesla's US market share has recovered to 52% after a sharp decline in 2025 linked to CEO Elon Musk's political ties, which hurt brand loyalty and wiped out over $500 billion in market value. While overall US EV sales dropped 30% through August 2026, ...

Market News
Bullish
4 hours ago
Oracle stock set for 121% rebound as cloud growth and AI boost optimism.

Oracle stock set for 121% rebound as cloud growth and AI boost optimism.

Oracle's stock has fallen over 52% in the past year but is expected to recover strongly, with Mizuho Securities predicting a 121% rise to $320 in the next 12 months. This optimism is driven by accelerating cloud infrastructure growth and disciplined ...

Analyst Insights
Bullish
4 hours ago
Musk and Cramer agree AI panic is driven by profit motives but differ on investor impact and safety solutions.

Musk and Cramer agree AI panic is driven by profit motives but differ on investor impact and safety solutions.

Elon Musk and Jim Cramer both suspect that AI doom warnings from leading labs are motivated by commercial interests. Musk proposes a peer-review safety system where AI companies test each other's models to prevent harmful behavior, emphasizing the ne...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App